相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents
J. Tol et al.
ANNALS OF ONCOLOGY (2010)
Extensive Lymphatic Spread of Cancer Cells in Patients With Thoracic Esophageal Squamous Cell Carcinoma: Detection of CEA-mRNA in the Three-Field Lymph Nodes
Yu Imamura et al.
JOURNAL OF SURGICAL ONCOLOGY (2010)
Colorectal Cancer Screening
Randall W. Burt et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2010)
Evaluation of Circulating Tumor Cells and Serological Cell Death Biomarkers in Small Cell Lung Cancer Patients Undergoing Chemotherapy
Jian-Mei Hou et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer
S. J. Cohen et al.
ANNALS OF ONCOLOGY (2009)
Circulating Tumor Cells in Patients with Castration-Resistant Prostate Cancer Baseline Values and Correlation with Prognostic Factors
Oscar B. Goodman et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer
Tina Fan et al.
GYNECOLOGIC ONCOLOGY (2009)
Diagnostic precision of carcinoembryonic antigen in the detection of recurrence of colorectal cancer
Emile Tan et al.
SURGICAL ONCOLOGY-OXFORD (2009)
Circulating tumor cells in colorectal cancer:: correlation with clinical and pathological variables
J. Sastre et al.
ANNALS OF ONCOLOGY (2008)
Clinical Significance of Circulating Tumor Cells in Blood from Patients with Gastrointestinal Cancers
Kunihiko Hiraiwa et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Circulating Tumor Cells in Metastatic Breast Cancer From Prognostic Stratification to Modification of the Staging System?
Shaheenah Dawood et al.
CANCER (2008)
Circulating Tumor Cell Detection Predicts Early Metastatic Relapse After Neoadjuvant Chemotherapy in Large Operable and Locally Advanced Breast Cancer in a Phase II Randomized Trial
Jean-Yves Pierga et al.
CLINICAL CANCER RESEARCH (2008)
Usefulness of the serum carcinoembryonic antigen kinetic for chemotherapy monitoring in patients with unresectable metastasis of colorectal cancer
Isabelle Iwanicki-Caron et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer
Steven J. Cohen et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Transcription-reverse transcription concerted reaction and minimal residual disease in axillary sentinel nodes of breast cancer
T. Ishikawa et al.
EJSO (2007)
Multiple molecular markers as predictors of colorectal cancer in patients with normal perioperative serum carcinoembryonic antigen levels
Jaw-Yuan Wang et al.
CLINICAL CANCER RESEARCH (2007)
ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer
Gershon Y. Locker et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Overall survival of patients with advanced colorectal cancer correlates with availability of fluorouracil, irinotecan, and oxaliplatin regardless of whether doublet or single-agent therapy is used first line
A Grothey et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Persistent evidence of circulating tumor cells detected by means of RT-PCR for CEA mRNA predicts early relapse: A prospective study in node-negative breast cancer
T Jotsuka et al.
SURGERY (2004)
Rapid genetic diagnosis with the transcription-reverse transcription concerted reaction system for cancer micrometastasis
T Ishii et al.
ANNALS OF SURGICAL ONCOLOGY (2004)
Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer
D Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
H Hurwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
A Randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer
RM Goldberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases
WJ Allard et al.
CLINICAL CANCER RESEARCH (2004)
Detection of breast cancer cells in the peripheral blood is positively correlated with estrogen-receptor status and predicts for poor prognosis
JJ Gaforio et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer.
LB Saltz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer
A de Gramont et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial
JY Douillard et al.
LANCET (2000)
分享论文
